Really good new for AUPH. Buckle Up as this will launch this week I expect...
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options
[Zacks]
Zacks Equity Research
ZacksOctober 16, 2017
Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 20, 2017 $5 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?
Clearly, options traders are pricing in a big move for Aurinia Pharmaceuticals shares, but what is the fundamental picture for the company? Currently, Aurinia Pharmaceuticals is a Zacks Rank #1 (Strong Buy) in the Medical - Drugs industry that ranks in the Bottom 42% of our Zacks Industry Rank. Over the last 30 days, our Zacks Consensus Estimate for the current quarter has moved from a loss of 13 cents per share to a loss of 16 cents.
Given the way analysts feel about Aurinia Pharmaceuticals right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
